Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Clark James David	2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) SVP, Cont & Chief Acct Officer
(Last)          (First)          (Middle) ONE CVS DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 4/1/2020
(Street) WOONSOCKET, RI 02895 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	4/1/2020		F		681 (1)	D	$58.34	11321.2554	D
Common Stock (restricted)	4/1/2020		A		7713 (2)	A	$58.34	20204	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$58.34	4/1/2020		A		17157		4/1/2021 (3)	4/1/2030	Common Stock	17157	$58.34	17157	D
Stock Option	$74.29							4/1/2015 (4)	4/1/2021	Common Stock	5350		5350	D
Stock Option	$102.26							4/1/2016 (5)	4/1/2022	Common Stock	6059		6059	D
Stock Option	$104.82							4/1/2017 (6)	4/1/2023	Common Stock	7044		7044	D
Stock Option	$78.05							4/3/2018 (7)	4/3/2024	Common Stock	9050		9050	D
Stock Option	$62.21							4/1/2019 (8)	4/1/2025	Common Stock	7513		7513	D
Stock Option	$54.19							4/1/2020 (9)	4/1/2029	Common Stock	24240		24240	D

Explanation of Responses:
(1)	Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards.
(2)	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2021.
(3)	Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
(4)	Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.
(5)	Options became exercisable in four equal annual installments beginning on 4/1/2016.
(6)	Options became exercisable in four equal annual installments beginning on 4/1/2017.
(7)	Options became exercisable in four equal annual installments beginning on 4/3/2018.
(8)	Options became exercisable in four equal annual installments, commencing 4/1/2019.
(9)	Options became exercisable in four equal annual installments, commencing 4/1/2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Clark James David ONE CVS DRIVE WOONSOCKET, RI 02895			SVP, Cont & Chief Acct Officer

Signatures
/s/ James D. Clark		4/3/2020
**Signature of Reporting Person		Date